pentoxifylline has been researched along with Parkinsonian Disorders in 1 studies
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline is a synthetic derivative of xantine which stimulates adenosine receptors, inhibit phosphodiesterase and increases cyclic monophosphate adenosine." | 1.31 | [Parkinsonism or Parkinson's disease unmasked by pentoxifylline?]. ( Serrano-Dueñas, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Serrano-Dueñas, M | 1 |
1 other study available for pentoxifylline and Parkinsonian Disorders
| Article | Year |
|---|---|
[Parkinsonism or Parkinson's disease unmasked by pentoxifylline?].
Topics: Aged; Aged, 80 and over; Female; Humans; Male; Parkinson Disease; Parkinson Disease, Secondary; Park | 2001 |